Cart
sales@molnova.com
Home - Products - Angiogenesis - CDK - CDK9-IN-2

CDK9-IN-2

CAS No. 1269815-17-9

CDK9-IN-2( CDK9 inhibitor II )

Catalog No. M11131 CAS No. 1269815-17-9

CDK9-IN-2 is a potent and selective CDK9 inhibitor with IC50 of <8 nM, example 4 in patent WO2011026917A1.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 93 In Stock
2MG 47 In Stock
5MG 88 In Stock
10MG 141 In Stock
25MG 272 In Stock
50MG 389 In Stock
100MG 551 In Stock
200MG Get Quote In Stock
500MG 1097 In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    CDK9-IN-2
  • Note
    Research use only, not for human use.
  • Brief Description
    CDK9-IN-2 is a potent and selective CDK9 inhibitor with IC50 of <8 nM, example 4 in patent WO2011026917A1.
  • Description
    CDK9-IN-2 is a potent and selective CDK9 inhibitor with IC50 of <8 nM, example 4 in patent WO2011026917A1.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    CDK9 inhibitor II
  • Pathway
    Angiogenesis
  • Target
    CDK
  • Recptor
    CDK
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1269815-17-9
  • Formula Weight
    363.8138
  • Molecular Formula
    C18H19ClFN3O2
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    COC1=C(C=C(C=C1)F)C2=CC(=NC=C2Cl)NC(=O)C3CCCNC3
  • Chemical Name
    3-Piperidinecarboxamide, N-[5-chloro-4-(5-fluoro-2-methoxyphenyl)-2-pyridinyl]-, (3R)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Keith B Pfister, et al. Heteroaryl compounds as kinase inhibitors. 2011, WO2011026917A1.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Abemaciclib metaboli...

    Abemaciclib metabolite M20 is an active metabolite of Abemaciclib.

  • Kenpaullone

    Kenpaullone (9-Bromopaullone,NSC-664704) is a potent inhibitor of CDK1/cyclin B with IC50 of 0.4 uM, also inhibited CDK2/cyclin A (IC50=0.68 uM), CDK2/cyclin E (IC50-7.5 uM) and CDK5/p25 (IC50=0.85 uM).

  • CAN-508

    CAN-508 is a potent, selective CDK9 inhibitor with IC50 of 0.35 uM (CDK9/cyclin T1), displays >35 fold selectivity over CDK1/2/4/7 (IC50=13.5-70 uM).

Sign In Join Free